ZC3HC1
{{Short description|Protein-coding gene in the species Homo sapiens}}
{{Infobox_gene}}
Nuclear-interacting partner of ALK (NIPA), also known as zinc finger C3HC-type protein 1 (ZC3HC1), is a protein that in humans is encoded by the ZC3HC1 gene on chromosome 7.{{cite journal | vauthors = Zhang QH, Ye M, Wu XY, Ren SX, Zhao M, Zhao CJ, Fu G, Shen Y, Fan HY, Lu G, Zhong M, Xu XR, Han ZG, Zhang JW, Tao J, Huang QH, Zhou J, Hu GX, Gu J, Chen SJ, Chen Z | title = Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells | journal = Genome Research | volume = 10 | issue = 10 | pages = 1546–60 | date = October 2000 | pmid = 11042152 | pmc = 310934 | doi = 10.1101/gr.140200 }}{{cite web | title = Entrez Gene: ZC3HC1 zinc finger, C3HC-type containing 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51530}} It is ubiquitously expressed in many tissues and cell types though exclusively expressed in the nuclear subcellular location.{{Cite web|url=http://biogps.org/#goto=genereport&id=51530|title=BioGPS - your Gene Portal System|website=biogps.org|access-date=2016-10-11}} NIPA is a skp1 cullin F-box (SCF)-type ubiquitin E3 ligase (SCFNIPA) complex protein involved in regulating entry into mitosis. The ZC3HC1 gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.{{cite journal | vauthors = Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield MJ, Devlin JJ, Nordio F, Hyde CL, Cannon CP, Sacks FM, Poulter NR, Sever PS, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS | title = Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials | journal = Lancet | volume = 385 | issue = 9984 | pages = 2264–71 | date = June 2015 | pmid = 25748612 | doi = 10.1016/S0140-6736(14)61730-X | pmc=4608367}}
Structure
= Gene =
The ZC3HC1 gene resides on chromosome 7 at the band 7q32.2 and includes 14 exons.
= Protein =
NIPA is a 60-kDa E3 ligase that contains one C3HC-type zinc finger and one F-box-like region.{{cite journal | vauthors = Ouyang T, Bai RY, Bassermann F, von Klitzing C, Klumpen S, Miething C, Morris SW, Peschel C, Duyster J | title = Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA) | journal = The Journal of Biological Chemistry | volume = 278 | issue = 32 | pages = 30028–36 | date = August 2003 | pmid = 12748172 | doi = 10.1074/jbc.M300883200 | doi-access = free }}{{cite journal | vauthors = Kunnas T, Nikkari ST | title = Association of Zinc Finger, C3HC-Type Containing 1 (ZC3HC1) rs11556924 Genetic Variant With Hypertension in a Finnish Population, the TAMRISK Study | journal = Medicine | volume = 94 | issue = 32 | pages = e1221 | date = August 2015 | pmid = 26266351 | doi = 10.1097/MD.0000000000001221 | pmc=4616712}}{{Cite web|url=https://www.uniprot.org/uniprot/Q86WB0|title=ZC3HC1 - Nuclear-interacting partner of ALK - Homo sapiens (Human) - ZC3HC1 gene & protein|website=www.uniprot.org|access-date=2016-10-11}} Moreover, a 50-residue region (amino acids 352-402) at its C-terminal serves as the nuclear translocation signal (NLS sequence) while a 96-residue region (amino acids 306-402) is proposed to serve as the phosphotyrosine-binding domain.{{cite journal | vauthors = Bassermann F, von Klitzing C, Illert AL, Münch S, Morris SW, Pagano M, Peschel C, Duyster J | title = Multisite phosphorylation of nuclear interaction partner of ALK (NIPA) at G2/M involves cyclin B1/Cdk1 | journal = The Journal of Biological Chemistry | volume = 282 | issue = 22 | pages = 15965–72 | date = June 2007 | pmid = 17389604 | doi = 10.1074/jbc.M610819200 | doi-access = free }} NIPA is one component of the nuclear SCFNIPA complex, and phosphorylation of NIPA at three serine residues, Ser-354, Ser-359 and Ser-395, has been demonstrated to inactivate the complex as a whole.
Function
NIPA is broadly expressed in the human tissues, with the highest expression in heart, skeletal muscle, and testis. It is a human F-box protein that defines an SCF-type ubiquitin E3 ligase, the formation of which is regulated by cell-cycle-dependent phosphorylation of NIPA. Cyclin B1, essential in the entry into mitosis, is targeted by SCFNIPA in interphase. Phosphorylation of NIPA occurs in G2 phase, results in dissociation of NIPA from the SCF core, and has been proven critical for proper G2/M transition.{{cite journal | vauthors = Bassermann F, von Klitzing C, Münch S, Bai RY, Kawaguchi H, Morris SW, Peschel C, Duyster J | title = NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry | journal = Cell | volume = 122 | issue = 1 | pages = 45–57 | date = July 2005 | pmid = 16009132 | doi = 10.1016/j.cell.2005.04.034 | s2cid = 16122567 | doi-access = free }} Oscillating ubiquitination of nuclear cyclin B1 driven by the SCFNIPA complex contributes to the timing of mitotic entry.{{cite journal | vauthors = Bassermann F, Peschel C, Duyster J | title = Mitotic entry: a matter of oscillating destruction | journal = Cell Cycle | volume = 4 | issue = 11 | pages = 1515–7 | date = November 2005 | pmid = 16258267 | doi = 10.4161/cc.4.11.2192 | doi-access = free }} NIPA is also reported to delay apoptosis and the localization of NIPA is required for this antiapoptotic function.
Clinical relevance
In humans, NIPA has been implicated in cardiovascular diseases by genome-wide association (GWAS) studies. Specifically, a single-nucleotide polymorphism (SNP) situated in ZC3HC1 has been shown to predict coronary artery disease.{{cite journal | vauthors = Jones PD, Kaiser MA, Ghaderi Najafabadi M, McVey DG, Beveridge AJ, Schofield CL, Samani NJ, Webb TR | title = The Coronary Artery Disease-associated Coding Variant in Zinc Finger C3HC-type Containing 1 (ZC3HC1) Affects Cell Cycle Regulation | journal = The Journal of Biological Chemistry | volume = 291 | issue = 31 | pages = 16318–27 | date = July 2016 | pmid = 27226629 | doi = 10.1074/jbc.M116.734020 | pmc=4965579| doi-access = free }}{{cite journal | vauthors = Jones PD, Kaiser MA, Ghaderi Najafabadi M, McVey DG, Beveridge AJ, Schofield CL, Samani NJ, Webb TR | title = The Coronary Artery Disease-associated Coding Variant in Zinc Finger C3HC-type Containing 1 (ZC3HC1) Affects Cell Cycle Regulation | journal = The Journal of Biological Chemistry | volume = 291 | issue = 31 | pages = 16318–27 | date = July 2016 | pmid = 27226629 | pmc = 4965579 | doi = 10.1074/jbc.M116.734020 | doi-access = free }} This prediction appears to be independent of traditional risk factors for cardiovascular disease such as high cholesterol levels, high blood pressure, obesity, smoking and diabetes mellitus, which are primary targets of current treatments for coronary artery disease. Therefore, studying the function of this gene may identify novel pathways contributing to coronary artery disease that result in the development of novel therapeutics.
= Clinical marker =
At the coronary artery disease-associated locus 7q32.2, only a single SNP (rs11556924) is associated with coronary artery disease risk, with no other variants in strong linkage disequilibrium. The rs11556924 SNP in the ZC3HC1 gene results in an arginine-histidine polymorphism at amino acid residue 363 in NIPA.{{cite journal | pmid = 16009132 | doi=10.1016/j.cell.2005.04.034 | volume=122 | issue=1 | title=NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry | date=July 2005 | journal=Cell | pages=45–57 | vauthors=Bassermann F, von Klitzing C, Münch S et al| s2cid=16122567 | doi-access=free }} Furthermore, rs11556924 has also been associated with altered carotid intima-media thickness in patients with rheumatoid arthritis{{cite journal | vauthors = López-Mejías R, Genre F, García-Bermúdez M, Corrales A, González-Juanatey C, Llorca J, Miranda-Filloy JA, Rueda-Gotor J, Blanco R, Castañeda S, Martín J, González-Gay MA | title = The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis | journal = Arthritis Research & Therapy | volume = 15 | issue = 5 | pages = R152 | date = 2013-01-01 | pmid = 24286297 | doi = 10.1186/ar4335 | pmc=3978706 | doi-access = free }} and with altered risk of atrial fibrillation.{{cite journal | vauthors = Yamase Y, Kato K, Horibe H, Ueyama C, Fujimaki T, Oguri M, Arai M, Watanabe S, Murohara T, Yamada Y | title = Association of genetic variants with atrial fibrillation | journal = Biomedical Reports | volume = 4 | issue = 2 | pages = 178–182 | date = February 2016 | pmid = 26893834 | doi = 10.3892/br.2015.551 | pmc=4734142}}
Additionally, a multi-locus genetic risk score study based on a combination of 27 loci, including the ZC3HC1 gene, identified individuals at increased risk for both incident and recurrent coronary artery disease events, as well as an enhanced clinical benefit from statin therapy. The study was based on a community cohort study (the Malmo Diet and Cancer study) and four additional randomized controlled trials of primary prevention cohorts (JUPITER and ASCOT) and secondary prevention cohorts (CARE and PROVE IT-TIMI 22).
References
{{reflist|33em}}
Further reading
{{refbegin|33em}}
- {{cite journal | vauthors = Dias Neto E, Correa RG, Verjovski-Almeida S, Briones MR, Nagai MA, da Silva W, Zago MA, Bordin S, Costa FF, Goldman GH, Carvalho AF, Matsukuma A, Baia GS, Simpson DH, Brunstein A, de Oliveira PS, Bucher P, Jongeneel CV, O'Hare MJ, Soares F, Brentani RR, Reis LF, de Souza SJ, Simpson AJ | title = Shotgun sequencing of the human transcriptome with ORF expressed sequence tags | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 97 | issue = 7 | pages = 3491–6 | date = March 2000 | pmid = 10737800 | pmc = 16267 | doi = 10.1073/pnas.97.7.3491 | bibcode = 2000PNAS...97.3491D | doi-access = free }}
- {{cite journal | vauthors = Hartley JL, Temple GF, Brasch MA | title = DNA cloning using in vitro site-specific recombination | journal = Genome Research | volume = 10 | issue = 11 | pages = 1788–95 | date = November 2000 | pmid = 11076863 | pmc = 310948 | doi = 10.1101/gr.143000 }}
- {{cite journal | vauthors = Ouyang T, Bai RY, Bassermann F, von Klitzing C, Klumpen S, Miething C, Morris SW, Peschel C, Duyster J | title = Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA) | journal = The Journal of Biological Chemistry | volume = 278 | issue = 32 | pages = 30028–36 | date = August 2003 | pmid = 12748172 | doi = 10.1074/jbc.M300883200 | doi-access = free }}
- {{cite journal | vauthors = Wiemann S, Arlt D, Huber W, Wellenreuther R, Schleeger S, Mehrle A, Bechtel S, Sauermann M, Korf U, Pepperkok R, Sültmann H, Poustka A | title = From ORFeome to biology: a functional genomics pipeline | journal = Genome Research | volume = 14 | issue = 10B | pages = 2136–44 | date = October 2004 | pmid = 15489336 | pmc = 528930 | doi = 10.1101/gr.2576704 }}
- {{cite journal | vauthors = Bassermann F, von Klitzing C, Münch S, Bai RY, Kawaguchi H, Morris SW, Peschel C, Duyster J | title = NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry | journal = Cell | volume = 122 | issue = 1 | pages = 45–57 | date = July 2005 | pmid = 16009132 | doi = 10.1016/j.cell.2005.04.034 | s2cid = 16122567 | doi-access = free }}
- {{cite journal | vauthors = Ambrogio C, Voena C, Manazza AD, Piva R, Riera L, Barberis L, Costa C, Tarone G, Defilippi P, Hirsch E, Boeri Erba E, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R | title = p130Cas mediates the transforming properties of the anaplastic lymphoma kinase | journal = Blood | volume = 106 | issue = 12 | pages = 3907–16 | date = December 2005 | pmid = 16105984 | pmc = 1895100 | doi = 10.1182/blood-2005-03-1204 }}
- {{cite journal | vauthors = Mehrle A, Rosenfelder H, Schupp I, del Val C, Arlt D, Hahne F, Bechtel S, Simpson J, Hofmann O, Hide W, Glatting KH, Huber W, Pepperkok R, Poustka A, Wiemann S | title = The LIFEdb database in 2006 | journal = Nucleic Acids Research | volume = 34 | issue = Database issue | pages = D415–8 | date = January 2006 | pmid = 16381901 | pmc = 1347501 | doi = 10.1093/nar/gkj139 }}
- {{cite journal | vauthors = Beausoleil SA, Villén J, Gerber SA, Rush J, Gygi SP | title = A probability-based approach for high-throughput protein phosphorylation analysis and site localization | journal = Nature Biotechnology | volume = 24 | issue = 10 | pages = 1285–92 | date = October 2006 | pmid = 16964243 | doi = 10.1038/nbt1240 | s2cid = 14294292 }}
- {{cite journal | vauthors = Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M | title = Global, in vivo, and site-specific phosphorylation dynamics in signaling networks | journal = Cell | volume = 127 | issue = 3 | pages = 635–48 | date = November 2006 | pmid = 17081983 | doi = 10.1016/j.cell.2006.09.026 | s2cid = 7827573 | doi-access = free }}
{{refend}}